|
| |
Articles
1-73 out of 73 article(s)
| Title |
Author |
Type |
Date |
Words |
| A case of eosinophilic ulcer localized at lower lip/Alt dudakta yerlesen bir eozinofilik ulser olgusu. |
Yetkin, Hicran; Basak, Pinar Yuksel; Akkaya, Vahide Baysal; Inan, Gulsun; Kapucuoglu, Nilgun |
Report |
Dec 1, 2009 |
1555 |
| How to stop the pain when you sit down; ASK THE DOCTOR; Every week Dr Martin Scurr, a top GP, answers your questions. |
|
|
Dec 1, 2009 |
1081 |
| Results of Phase I Study Show Novel, Investigational PA65020 Compound Significantly Decreased Risk of Upper GI Damage in Healthy Adults. |
|
|
Oct 27, 2009 |
899 |
| Mastic through the ages. |
Gordin, Karina L. |
Report |
Oct 1, 2009 |
2506 |
| Life on the edge: the clinical implications of gastrointestinal biofilm. |
Olmstead, Stephen; Meiss, Dennis; Ralston, Janet |
Report |
Oct 1, 2009 |
4476 |
| Eisai Submits Application for Additional Indication of its Proton Pump Inhibitor PARIET(R) for Non-erosive GERD in Japan. |
|
|
Sep 29, 2009 |
425 |
| Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gastrointestinal Injuries. |
|
Clinical report |
Jul 1, 2009 |
1291 |
| Elusive victory a landmark for sire; French Guineas heroine shows progeny do train on. |
|
|
May 12, 2009 |
1476 |
| Study validates gastric anti-ulcer properties of herb medicine Rocket 'Eruca sativa'. |
|
|
May 9, 2009 |
271 |
| Common heartburn drugs may reduce anti-clotting medications' benefits. |
|
|
May 7, 2009 |
502 |
| Pharmacology Watch: FDA Warning: Pharmaceuticals in "Natural" Products. |
|
|
May 1, 2009 |
1249 |
| Restrictions on business relationships with industries, and their unintended adverse consequences. |
Sataloff, Robert T. |
|
May 1, 2009 |
2422 |
| Pharmacology Watch: FDA Warning: Pharmaceuticals in. |
|
|
May 1, 2009 |
1245 |
| Refractory gastro-oesophageal reflux disease can be frustrating, for both patient and practitioner. (Refractory gastro-oesophageal reflux disease: a major management issue in clinical practice. |
van Rensburg, Christo |
Report |
May 1, 2009 |
2628 |
| Gastric cancer is a common form of cancer which generally has a poor prognosis. |
Fritz, Elongo Lekunze; van der Merwe, Schalk Willem |
Disease/Disorder overview |
May 1, 2009 |
2619 |
| Ulcer drugs with ibuprofen may offer Alzheimer's treatment. |
|
|
Apr 23, 2009 |
289 |
| Santarus Announces FDA Acceptance of New Drug Application for ZEGERID Tablet Product. |
|
|
Apr 6, 2009 |
1208 |
| Soon, anti-ulcer yoghurt. |
|
|
Mar 23, 2009 |
321 |
| What has caused my painful chilblains? ASK THE DOCTOR; Every week Dr Martin Scurr, a top GP, answers your questions. |
|
|
Mar 17, 2009 |
1152 |
| What has caused my painful chilblains? ASK THE DOCTOR Every week Dr Martin Scurr, a top GP, answers your questions. |
|
|
Mar 17, 2009 |
1045 |
| Sucampo Completes Enrollment in Its Phase 2 Trial of Cobiprostone for the Prevention of NSAID-Induced Ulcers. |
|
|
Jan 8, 2009 |
1032 |
| Canada: The IP Year 2008 In Review: Patents (Part 1 of 3). |
|
|
Dec 23, 2008 |
8572 |
| Meda: First Combination of NSAID and Proton Pump Inhibitor Approved. |
|
|
Dec 9, 2008 |
322 |
| Will light therapy help beat my blues? |
|
|
Dec 2, 2008 |
1043 |
| This natural solution to acid reflux is safer and less expensive than antacids. |
|
Clinical report |
Dec 1, 2008 |
1300 |
| Santarus Reports Third Quarter 2008 Financial Results. |
|
Financial report |
Nov 3, 2008 |
2512 |
| New foci of Buruli ulcer, Angola and Democratic Republic of Congo. |
Kibadi, Kapay; Panda, Mbutu; Tamfum, Jean-Jacques Muyembe; Fraga, Alexandra G.; Filho, Adhemar Longa |
|
Nov 1, 2008 |
2084 |
| Johnson loses Sedgefield appeal. |
|
|
Sep 19, 2008 |
260 |
| POZEN To Present at The UBS Life Sciences Conference. |
|
Conference news |
Sep 10, 2008 |
219 |
| POZEN Sponsors Habitat for Humanity Home in Hillsborough, North Carolina. |
|
|
Sep 8, 2008 |
438 |
| POZEN To Present at the 3rd Annual Citi Biotech Day. |
|
|
Aug 26, 2008 |
201 |
| vital: Ulcers not diet related. |
|
|
Aug 25, 2008 |
350 |
| Indigestion drug 'can raise brittle bone risk'. |
|
|
Aug 16, 2008 |
598 |
| POZEN Receives Initial FDA Response To PA32540 SPA. |
|
|
Aug 1, 2008 |
680 |
| POZEN Reports Second Quarter 2008 Results. |
|
|
Jul 29, 2008 |
1142 |
| POZEN to Present at the 2008 BMO Capital Markets Focus on Healthcare Conference. |
|
Conference news |
Jul 24, 2008 |
220 |
| POZEN Announces July 29, 2008 Webcast of Second Quarter 2008 Results. |
|
|
Jul 15, 2008 |
242 |
| Low Levels of Diagnosis and New Biological Approaches to Treatment Indicate a Positive Future for Gastrointestinal Drugs. |
|
|
Jun 18, 2008 |
788 |
| POZEN To Present at the Jefferies 2nd Annual Healthcare Conference. |
|
Conference news |
Jun 16, 2008 |
212 |
| POZEN Demonstrates Bioequivalence to Enteric Coated Aspirin for PA32540. |
|
|
Jun 9, 2008 |
747 |
| POZEN To Present at the Seventh Annual Needham & Co., LLC Biotechnology & Medical Technology Conference. |
|
Conference news |
Jun 2, 2008 |
203 |
| POZEN Announces PN 200 Podium Presentation at Digestive Disease Week. |
|
|
May 19, 2008 |
856 |
| POZEN To Present at the Citigroup Global Healthcare Conference. |
|
Conference news |
May 15, 2008 |
202 |
| POZEN IND and NDA for Treximet(TM) (Sumatriptan/Naproxen Sodium) Transferred to GlaxoSmithKline. |
|
|
May 14, 2008 |
561 |
| POZEN Reports First Quarter 2008 Results. |
|
Financial report |
May 8, 2008 |
1056 |
| POZEN To Present at Baird's 2008 Growth Stock Conference. |
|
Conference news |
May 1, 2008 |
204 |
| POZEN Announces Receipt of $20 Million in Milestone Payments from GlaxoSmithKline. |
|
|
Apr 28, 2008 |
824 |
| POZEN Announces May 8, 2008 Webcast of First Quarter 2008 Results. |
|
|
Apr 25, 2008 |
248 |
| Get the Most Health for Your Pharmacy Dollars. |
|
|
Apr 22, 2008 |
1002 |
| Exeter. |
|
Brief article |
Dec 7, 2007 |
79 |
| Antiulcerogenic potential of Strychnos potatorum Linn seeds on aspirin plus pyloric ligation-induced ulcers in experimental rats. |
Sanmugapriya, E.; Venkataraman, S. |
Clinical report |
May 1, 2007 |
3335 |
| Effects of water extract of Usnea longissima on antioxidant enzyme activity and mucosal damage caused by indomethacin in rats. |
Halici, M.; Odabasoglu, F.; Suleyman, H.; Cakir, A.; Aslan, A.; Bayir, Y. |
|
Sep 1, 2005 |
4884 |
| Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. |
Sertie, J.A.A.; Woisky, R.G.; Wiezel, G.; Rodrigues, M. |
|
May 1, 2005 |
4071 |
| Anti-ulcer and anti-oxidant activity of Pepticare, a herbomineral formulation. |
Bafna, P.A.; Balaraman, R. |
|
Apr 1, 2005 |
5170 |
| Antiulcerogenic activity of a crude hydroalcoholic extract and coumarin isolated from Mikania laevigata Schultz Bip. |
Bighetti, A.E.; Antonio, M.A.; Kohn, L.K.; Rehder, V.L.G.; Foglio, M.A.; Possenti, A.; Vilela, L.; C |
|
Jan 1, 2005 |
4296 |
| For second-trimester abortion, women given misoprostol vaginally report the greatest satisfaction. |
Hollander, D. |
|
May 1, 2004 |
733 |
| In vitro evaluation of Bacopa monniera on anti-Helicobacter pylori activity and accumulation of prostaglandins. |
Goel, R.K.; Sairam, K.; Babu, M. Dora; Tavares, I.A.; Raman, A. |
|
Jul 1, 2003 |
3388 |
| Anti-inflammatory and antiulcerogenic effects of the aqueous extract of Lobaria pulmonaria (L.) Hoffm. |
Suleyman, H.; Odabasoglu, F.; Aslan, A.; Cakir, A.; Karagoz, Y.; Gocer, F.; Halici, M.; Bayir, Y. |
|
Jul 1, 2003 |
3879 |
| Enterprise: biotech; Santarus seeks a spot in a highly competitive field. |
Webb, Marion |
|
Dec 16, 2002 |
1234 |
| Prevpac-TAP. |
|
|
Jul 1, 1999 |
815 |
| IntraBiotics Announces Results of Phase I Trial of Protegrin IB-367 for the Treatment of Oral Mucositis. |
|
|
Aug 27, 1998 |
565 |
| Novartis given approval by FDA to market Apligraf for the treatment of venous leg ulcers |
|
Article |
Jun 15, 1998 |
166 |
| Access Pharmaceuticals, Inc. Announces Agreement With Block Drug Company for the International Rights to Amlexanox. |
|
Article |
Jun 4, 1998 |
543 |
| Axcan Pharma Announces the Completion of its Canadian Multicentre Study for H. Pylori Eradication. |
|
|
Oct 20, 1997 |
381 |
| Bentley Pharmaceuticals receives approval to market new 28-capsule presentation of its ulcer product, Belmazol, in Spain. |
|
|
Feb 24, 1997 |
434 |
| AXID AR, the newest advance in heartburn prevention, cleared for OTC sale. |
|
|
May 9, 1996 |
625 |
| Carrington Laboratories receives additional 510(K) approval for the Carrington(TM) patch. |
|
|
May 1, 1996 |
437 |
| Organogenesis initiates pivotal trial on Graftskin for the treatment of Diabetic Ulcers. |
|
|
Mar 12, 1996 |
323 |
| ChemTrak files for FDA clearance of H.pylori test. |
|
|
Feb 5, 1996 |
563 |
| Cortecs enters into A$2.5 Million R&D syndication for the development of its oral Helicobacter pylori treatment. |
|
|
Jan 17, 1996 |
974 |
| Is there a relationship? Esophageal cancer and ulcer medication. |
Brown, Edwin W. |
|
Dec 1, 1995 |
775 |
| SPAN-AMERICA REPORTS 47% INCREASE IN FOURTH QUARTER EARNINGS; DECLARES QUARTERLY DIVIDEND. |
|
|
Oct 30, 1995 |
662 |
| ChemTrak and Astra Merck sign agreement for H. pylori test. |
|
|
Mar 2, 1995 |
755 |
|
